Anti-Snoring Devices Global Market Report 2024

The anti-snoring devices market has grown strongly in recent years. It will grow from $1.67 billion in 2023 to $1.82 billion in 2024 at a compound annual growth rate (CAGR) of 9.0%. The growth observed in the historical period can be attributed to several factors, including increased awareness of sleep disorders, greater recognition of health risks associated with snoring, a growing aging population and prevalence of snoring, awareness of its impact on the quality of sleep, and the availability of non-invasive and over-the-counter options for addressing snoring. These factors collectively contributed to the development and adoption of anti-snoring devices and solutions during this period.

The anti-snoring devices market is expected to see strong growth in the next few years. It will grow to $2.61 billion in 2028 at a compound annual growth rate (CAGR) of 9.3%. The anticipated growth in the forecast period can be attributed to a heightened focus on sleep health, the impact of increasing lifestyle-related factors on snoring, advancements in the design and comfort of anti-snoring devices, the growth of online retail and e-commerce, and the demand for customized and personalized solutions. Major trends expected in the forecast period include the application of neuromodulation technologies, the integration of biofeedback mechanisms, a heightened focus on comfort and user experience, collaboration with sleep clinics and professionals, and the expansion of retail channels and e-commerce for the distribution of anti-snoring devices.

The surge in obesity prevalence is anticipated to propel the expansion of the anti-snoring devices market in the foreseeable future. Obesity, characterized by abnormal or excessive weight gain that poses health risks, has prompted the demand for anti-snoring devices such as mouthpieces. These devices aid individuals managing obesity-related snoring by adjusting the jaw forward, thereby preventing the tongue from obstructing the airway during sleep. As reported by the World Obesity Federation in 2020, approximately 770 million adults worldwide were affected by obesity, with projections indicating an escalation to over one billion by 2030. Consequently, the burgeoning prevalence of obesity is a significant driver behind the growth trajectory of the anti-snoring devices market.

The rising prevalence of snoring is poised to propel the expansion of the anti-snoring devices market in the forthcoming years. Snoring, a common sleep-related sound caused by partial blockage of airflow through the mouth and nose during sleep, has led to an increased demand for anti-snoring devices. These devices are meticulously designed to target the root causes of snoring and offer individuals relief from this sleep-related concern. According to statistics from DisturbMeNot, a US-based mattress manufacturing company in January 2022, approximately 45% of individuals experience occasional snoring, with 25% reporting regular occurrences. In the United States alone, an estimated 37 million individuals habitually snore, with a prevalence of 40% among men and 24% among women. Hence, the mounting prevalence of snoring significantly propels the expansion of the anti-snoring devices market.

Advancements in product innovation stand as a prominent trend gaining traction within the anti-snoring devices market. Companies engaged in this sector are actively innovating their product offerings to maintain their market standing. For example, in February 2021, Signifier Medical Technologies LLC, a UK-based medical technology enterprise, introduced the eXciteOSA daytime therapy. This pioneering therapy aims to address mild obstructive sleep apnea and snoring in patients aged 18 and above. Remarkably, it represents the initial device specifically engineered to enhance tongue muscle functionality while patients are awake, thereby preventing the tongue from collapsing backward and obstructing the airway during sleep.

Leading entities in the anti-snoring devices market are directing their efforts towards the development of oral anti-snoring solutions. Oral anti-snoring devices are specialized tools crafted to mitigate snoring concerns by placement within the oral cavity during sleep. For instance, in June 2022, Illusion Aligners, a prominent global leader in dental restorations based in India, unveiled the ‘Illusion Aligner oral anti-snoring device.’ Renowned for its simplicity, the device is tailored to offer both efficacy and comfort, contributing to undisturbed and tranquil sleep patterns. Notably, this device aims to alleviate symptoms of obstructive sleep apnea (OSA), thereby reducing fatigue and stress while enhancing overall quality of life.

In October 2021, Kronos Advanced Technologies Inc., a US-based company specializing in computer and electronics manufacturing, successfully acquired Zyppah for an undisclosed amount. This strategic acquisition is aimed at improving the quality of life for the over 90 million adults in the USA who experience snoring issues. Zyppah, the acquired company, is a US-based medical equipment company that offers solutions for sleep apnea and snoring.

Major companies operating in the anti-snoring devices market report are Sleeping Well LLC,Apnea Sciences Corporation,Somnomed Ltd.,Airway Management Inc.,Theravent Inc.,Tomed Gmbh,GSK plc,MPowRx,Innovative Health Care Pvt. Ltd.,ResMed Inc.,Fisher & Paykel Appliances Holdings Ltd.,AccuMed Corp.,MEDiTAS Ltd.,Koninklijke Philips N.V.,ImThera Medical Inc.,Contour Products Inc.,VVFLY Electronics Co. Ltd.,ZQuiet,The Pure Sleep Company,Rhinomed Limited,DentCare Dental Lab Pvt. Ltd.,Signifier Medical Technologies LLC,Endo Pharmaceuticals Inc.,KARL STORZ SE & Co. KG,Lumenis Be Ltd.,Olympus Winter & IBE GMBH,Urologix LLC,Boston Scientific Corporation,Teleflex Incorporated,Richard Wolf GmbH,biolitec AG,Coloplast Corp.,Nozovent,Snoring Solutions Inc.

North America was the largest region in the anti-snoring devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global anti-snoring devices market report during the forecast period. The regions covered in the anti-snoring devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the anti-snoring devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The main types of anti-snoring devices include mandibular advancement devices (MADs), tongue retaining devices (TRD), nasal dilators, chin straps, position control devices, anti-snoring pillows, tongue stabilizing devices (TSD), and expiratory positive airway pressure (EPAP). Mandibular advancement devices (MADs) temporarily reposition the jaw and tongue by bringing the tongue forward, widening the airway to alleviate throat constriction and prevent snoring and sleep apnea. These devices are commonly used to address sleep apnea and snoring. Surgical procedures for snoring include uvulopalatopharyngoplasty (UP3), laser-assisted uvula palatoplasty (LAUP), radiofrequency ablation (RFA), sclerotherapy, pillar procedures, and others. These procedures are typically performed on individuals aged between 40 and 59 years, 60 and above years, and below 40 years. Anti-snoring devices and procedures are utilized by various healthcare settings, including hospitals, community healthcare centers, sleep clinics, home healthcare, and others.

The anti-snoring device market research report provides anti-snoring device market statistics, including the anti-snoring device industry global market size, regional shares, competitors with an anti-snoring device market share, detailed anti-snoring device market segments, market trends, and opportunities, and any further data you may need to thrive in the anti-snoring device industry. This anti-snoring device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The anti-snoring devices market consists of sales of external nasal dilators, non-custom mandibular advancement devices, custom-made mandibular advancement devices, 3-unit bridges, 4-unit bridges, Maryland bridges, cantilever bridges, complete dentures, partial dentures, temporary abutments, definitive abutments, straps, strips, mouthguards, and side sleepers. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.